Hii make a detailed treatment of Acne each and every type

Reading File
Finding Sources
Finding Sources
Searching PubMed

"acne vulgaris"[MeSH Terms] AND "therapy"[MeSH Terms]

Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
I now have comprehensive content from authoritative dermatology textbooks. Let me compile the complete, detailed treatment guide.

πŸ”΄ Comprehensive Treatment of Acne β€” All Types

Sources: Dermatology 2-Volume Set 5e (Elsevier), Andrews' Diseases of the Skin (13e), Harriet Lane Handbook (23e), Andrews' Diseases of the Skin, Katzung's Basic & Clinical Pharmacology

Part I: Understanding Acne β€” Types & Classification

Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit driven by four key pathogenic factors:
  1. Follicular hyperkeratinization β†’ comedone formation
  2. Sebaceous gland hyperactivity β†’ excess sebum (androgen-driven)
  3. Cutibacterium acnes (formerly P. acnes) colonization β†’ inflammation
  4. Inflammatory cascade β†’ papules, pustules, nodules, cysts

Lesion Types

LesionDescription
Open comedone (blackhead)Dilated follicle open to surface; oxidized lipids give dark color
Closed comedone (whitehead)Plugged follicle beneath skin surface
PapuleSmall, raised, red inflammatory lesion (<5 mm)
PustulePapule with visible purulent center
NoduleDeep, solid, painful lesion β‰₯5 mm
Cyst (pseudocyst)Fluctuant, deep nodule filled with pus/keratin debris

Clinical Subtypes

TypeKey Features
Comedonal acnePredominantly open/closed comedones, minimal inflammation
Mild papulopustularScattered papules and pustules, few comedones
Moderate papulopustularMultiple papules/pustules, few nodules
Nodular/cystic acneNumerous deep nodules/cysts, high scar risk
Acne conglobataSevere, interconnected nodules, abscesses, sinus tracts; mainly trunk; predominantly males
Acne fulminansSudden-onset severe nodular acne with systemic features (fever, arthralgia, leukocytosis, osteolytic lesions)
Neonatal acneBirth to 6 weeks; Malassezia driven; usually self-limiting
Infantile acne2 months–1 year; true comedonal/inflammatory
Acne mechanicaFriction/pressure-induced (helmets, straps)
Drug-induced acneCorticosteroids, lithium, androgens, halogens, phenytoin
Hormonal acne (females)Jawline/chin distribution; perimenstrual flares; associated with PCOS
RosaceaDistinct entity β€” no comedones; flushing; telangiectasia (not treated same as acne)

Part II: Severity-Based Treatment Algorithm

🟑 MILD ACNE

Definition: Several papules, pustules, and/or comedones; no nodules.

Comedonal Mild Acne

First-line:
  • Topical retinoid (tretinoin, adapalene, or tazarotene) Β± physical comedo extraction
Second-line:
  • Alternate retinoid; benzoyl peroxide (BPO); salicylic acid; azelaic acid

Papulopustular Mild Acne

First-line:
  • BPO or topical antimicrobial + topical retinoid
  • BPO wash for mild truncal lesions
Second-line:
  • Alternate antimicrobial + alternate retinoid; azelaic acid; sodium sulfacetamide-sulfur

🟠 MODERATE ACNE

Definition: Multiple papules and pustules; few scattered nodules; variable comedones.
First-line:
  • Topical retinoid + BPO Β± topical antibiotic
  • Oral antibiotic (doxycycline or minocycline) + topical retinoid + BPO
  • In women: Spironolactone and/or oral contraceptive + topical retinoid Β± BPO
Second-line:
  • Change oral antibiotic; alternate topical retinoid
  • If moderately severe or scars form β†’ oral isotretinoin
Oral antibiotics should be limited to 3–4 months and never used as monotherapy. They must always be paired with BPO to prevent resistance.

πŸ”΄ SEVERE ACNE (Nodular/Cystic)

Definition: Numerous papules and pustules; multiple nodules; variable comedones.
First-line:
  • Oral isotretinoin (drug of choice)
  • Oral antibiotic + topical retinoid + BPO Β± topical antibiotic
  • In women: Spironolactone + OCP + topical retinoid Β± topical/oral antibiotics Β± BPO
Procedural:
  • Intralesional triamcinolone acetonide (2.5–5 mg/mL) β€” especially for nodular and cystic lesions; rapid reduction of inflammation

Part III: Individual Drug Classes β€” Detailed

1. 🧴 TOPICAL RETINOIDS

Mechanism: Normalize follicular keratinization β†’ reduce comedones; potent anti-inflammatory (inhibit leukocytes, proinflammatory cytokines, TLRs); enhance penetration of co-applied agents.
AgentConcentrationNotes
Tretinoin0.025–0.05% cream; 0.025% gel (microsphere)Applied nightly; photosensitive; 8–12 weeks to effect
Adapalene0.1% gel (OTC), 0.3% gel (Rx)Light-stable β†’ morning or evening use; best tolerated; equivalent efficacy to lower tretinoin doses
Tazarotene0.05–0.1% gel/creamStrongest, most irritating; apply nightly; category X in pregnancy
Key practice points:
  • Apply to entire acne-prone area (not spot treatment)
  • Start every other night β†’ titrate to nightly as tolerated
  • Use daily SPF sunscreen
  • Avoid in pregnancy (all retinoids)
  • Retinoids are the preferred maintenance agents after initial control
β€” Andrews' Diseases of the Skin, p. 281; Harriet Lane Handbook, p. 282

2. 🫧 BENZOYL PEROXIDE (BPO)

Mechanism: Oxidizing agent β†’ bactericidal against C. acnes; mild comedolytic; no bacterial resistance develops.
Available forms: 2.5%, 5%, 10% β€” gels, creams, washes, foams.
Key practice points:
  • Apply once daily (usually morning) or twice daily
  • Washes effective for truncal acne; leave in contact β‰₯2 minutes
  • Use concurrently with antibiotics (topical or oral) to prevent resistance
  • Warning: Bleaches hair, clothing, towels, and sheets
  • Water-based, lowest-strength formulations are least irritating without compromising efficacy
β€” Harriet Lane Handbook, p. 282; Andrews' Diseases of the Skin

3. 🦠 TOPICAL ANTIBIOTICS

Agents: Clindamycin 1%, erythromycin 2% (gels, solutions, pledgets)
Mechanism: Inhibit C. acnes growth and reduce inflammation.
Key practice points:
  • Never use as monotherapy β€” must be combined with BPO to minimize antibiotic resistance
  • Concurrently use topical retinoid to hasten response and allow earlier antibiotic discontinuation
  • Well-tolerated; category B in pregnancy
  • Topical dapsone 5–7.5% gel: Alternative; apply twice daily; note skin discoloration if BPO applied afterward; hemolytic anemia risk (check G6PD in at-risk patients)
  • Topical minocycline 4% foam: Newer option under review

4. πŸ’Š ORAL ANTIBIOTICS

Indications: Moderate to severe inflammatory acne; disease on chest/back/shoulders; patients who scar with each lesion; failure of topical regimens.
Duration: Limit to 3–4 months; never as monotherapy.
DrugDoseNotes
Doxycycline50–100 mg once or twice dailyFirst-choice in most guidelines; photosensitivity, GI upset; sub-antimicrobial dose (40 mg/day modified-release) has similar efficacy, fewer side effects
Minocycline50–100 mg twice dailyEqually effective; higher risk of serious AEs: drug-induced lupus, hepatitis, pigmentation, hypersensitivity syndrome
SarecyclineWeight-based (~1.5 mg/kg/day)Narrow-spectrum tetracycline; approved β‰₯9 years; less GI/photo adverse effects
AzithromycinVariable pulse dosingFor patients unable to tolerate tetracyclines, pregnant, or <8 years; efficacy comparable to doxycycline, but resistance risk limits use
Erythromycin500 mg twice dailyPregnancy safe; increasing resistance worldwide
TMP-SMXNot recommended routineHigher risk severe reactions
Mechanism of tetracyclines: Suppress C. acnes + anti-inflammatory (↓TNF, ↓IL-1, ↓IL-6).
β€” Dermatology 5e, p. 728

5. β˜€οΈ ISOTRETINOIN (Oral Retinoid)

Indications:
  • Severe nodular/cystic acne
  • Moderate acne with scarring
  • Moderate acne that relapses quickly off oral antibiotics
  • Psychological distress despite adequate topical/systemic therapy
  • Acne conglobata and acne fulminans
Mechanism: Acts on all four pathogenic factors β€” dramatically reduces sebum production (↓sebaceous gland size 50–90%), normalizes follicular keratinization, reduces C. acnes, anti-inflammatory.
Dosing:
  • Standard: 0.5–1 mg/kg/day; total cumulative dose 120–150 mg/kg (for long-lasting remission)
  • Duration: typically 4–6 months
  • Split into two daily doses with food (fat enhances absorption)
Monitoring (iPLEDGE program in USA):
  • Monthly pregnancy tests in all females of childbearing potential (teratogen β€” Category X, absolute contraindication)
  • Monthly LFTs, fasting lipids (triglyceride elevation common)
  • Baseline and periodic CBC
Key adverse effects:
  • Mucocutaneous: Cheilitis (nearly universal), dry skin/eyes/nose, epistaxis
  • Teratogenicity: Two forms of contraception mandatory in females
  • Dyslipidemia: Hypertriglyceridemia; reduce dose or add fibrate if severe
  • Musculoskeletal: Myalgia, arthralgia
  • Psychiatric: Screen for depression/suicidal ideation (debated causal link)
  • Night blindness (rare)
  • Pseudotumor cerebri β€” avoid with tetracyclines simultaneously
Contraindications: Pregnancy, breastfeeding, hypervitaminosis A, hyperlipidemia (relative), hepatic disease.
β€” Dermatology 5e, p. 729; Andrews' Diseases of the Skin

6. 🩺 HORMONAL THERAPY (Females Only)

Indications: Female patients with inflammatory acne regardless of serum androgen levels; hormonal acne (jaw/chin); PCOS; acne worsening perimenstrually.

Combined Oral Contraceptive Pills (COCPs)

  • Mechanism: Suppress ovarian + adrenal androgen production via estrogen + progestin
  • Preferred progestins (anti-androgenic): Norgestimate, desogestrel, drospirenone (avoid androgenic progestins like levonorgestrel)
  • FDA-approved for acne: Ortho Tri-Cyclen (norgestimate/EE), Yaz (drospirenone/EE), Estrostep (norethindrone/EE)
  • Meta-analysis: COCPs equivalent to oral antibiotics in reducing acne lesions at 6 months
  • Takes 3–6 menstrual cycles for full effect

Spironolactone

  • Mechanism: Androgen receptor blocker + inhibits 5Ξ±-reductase; reduces sebum
  • Dose: 50–200 mg/day (start 50–100 mg, titrate)
  • Particularly effective for adult female hormonal acne (jawline pattern)
  • Side effects: Menstrual irregularity (co-prescribe with OCP), breast tenderness, hyperkalemia, hypotension
  • Monitor: K⁺, BP; avoid in renal failure or those on ACE inhibitors/ARBs
  • Pregnancy category X β€” contraception required
β€” Dermatology 5e, p. 728–729

7. πŸ”¬ OTHER TOPICAL AGENTS

AgentMechanismNotes
Azelaic acid 15% gel / 20% creamAntimicrobial, comedolytic, anti-inflammatory, antityrosinaseLightens post-inflammatory hyperpigmentation (PIH); Category B in pregnancy; well-tolerated
Salicylic acid 0.5–2%Ξ²-hydroxy acid; comedolytic (keratolytic)Available OTC; gentle alternative to retinoids; less potent
Clascoterone 1% creamTopical androgen receptor inhibitorApproved β‰₯12 years; for both males and females; 18–20% clear/almost clear vs 6–9% vehicle at 12 weeks
Niacinamide 2% gel↓Sebum; ↑ceramideNon-inferior to clindamycin 1% gel for moderate acne
Sodium sulfacetamide-sulfurMild antibacterial/keratolyticUseful for rosacea too; avoid sulfonamide allergy

Part IV: Special Acne Variants β€” Specific Treatments

πŸ”΄ Acne Conglobata

Severe interconnected nodules, sinuses, abscesses predominantly on trunk.
Treatment:
  • Oral isotretinoin is first-line (standard dosing protocol)
  • Oral antibiotic + topical retinoid + BPO as alternative
  • Intralesional triamcinolone for individual nodules
  • Surgery: incision and drainage of fluctuant abscesses
  • Biological agents (dapsone, colchicine) used in refractory cases

πŸ”₯ Acne Fulminans

Sudden explosive onset; systemic symptoms (fever, arthralgia, leukocytosis, weight loss, osteolytic lesions).
Treatment β€” Stepwise:
  1. Oral corticosteroids first (prednisolone 0.5–1 mg/kg/day) to suppress explosive inflammation β€” start 2–4 weeks BEFORE adding isotretinoin
  2. Then introduce isotretinoin at low dose (10–20 mg/day initially) while tapering steroids
  3. Gradually increase isotretinoin to standard dose
  4. Topical BPO + topical retinoid as adjuncts
  5. NSAIDs for arthralgia
⚠️ Do not start high-dose isotretinoin acutely in fulminans β€” it can worsen the flare.

πŸ‘Ά Neonatal & Infantile Acne

Neonatal acne (0–6 weeks):
  • Usually Malassezia-related (neonatal cephalic pustulosis)
  • Mostly self-resolving
  • If treatment needed: topical ketoconazole 2% cream
Infantile acne (2 months–2 years):
  • True comedonal and inflammatory acne; can be severe
  • First-line: Topical retinoid + topical BPO
  • Moderate–severe: Low-dose oral erythromycin (safest antibiotic in infants)
  • Check for underlying androgen excess (precocious puberty, CAH, androgen-secreting tumor)

πŸ’Š Drug-Induced Acne

Causative agents: Systemic corticosteroids, anabolic steroids, androgens, lithium, halogens (iodides, bromides), phenytoin, isoniazid, EGFR inhibitors.
Treatment:
  • Discontinue or substitute the offending drug whenever possible
  • Topical BPO + topical retinoid for mild/moderate lesions
  • Corticosteroid-induced acne: typically monomorphic pustular β€” responds to topical BPO; tetracyclines if widespread

πŸ‘© Hormonal/Adult Female Acne

  • Perimenstrual flares, jawline/lower face distribution, resistant to standard topicals
  • Spironolactone 50–200 mg/day Β± COCP (first-line in adult women)
  • Low-dose isotretinoin as alternative
  • Rule out PCOS, CAH, androgen-secreting tumor (free testosterone, DHEAS, LH/FSH if clinical suspicion)

πŸ‹οΈ Acne Mechanica

  • Due to friction, pressure, occlusion (helmets, chin straps, tight clothing)
  • Treatment: Remove/modify mechanical factor; topical BPO; topical retinoid; use moisture-wicking clothing

Part V: Procedural & Physical Treatments

ProcedureIndicationNotes
Comedo extractionComedonal acnePerformed with comedo extractor; adjunct to topical therapy
Intralesional triamcinolone (2.5–5 mg/mL)Nodular/cystic lesionsRapid resolution; risk of atrophy at high doses
Chemical peels (salicylic acid, glycolic acid)Comedonal, mild–moderateSuperficial peels; reduce PIH; adjunct therapy
Photodynamic therapy (PDT)Moderate–severe; antibiotic-resistantAminolevulinic acid + red/blue light; Level I evidence
Blue/red light therapyMild–moderate inflammatoryNon-photosensitizing; targets C. acnes porphyrins
Laser therapy (1450 nm diode, 585 nm PDL)Inflammatory lesions; scarringEffective for active disease and scars
Dermabrasion/microdermabrasionAcne scarringMechanical resurfacing for atrophic/ice-pick scars
SubcisionRolling/tethered scarsNeedle breaks fibrous bands under scars
Punch excision/graftingIce-pick scarsSurgical excision of individual deep scars
Fillers (hyaluronic acid)Atrophic rolling scarsTemporary volume restoration
Fractional COβ‚‚ laserAtrophic scarringGold standard for acne scar resurfacing

Part VI: Pregnancy-Safe Acne Treatment

⚠️ Isotretinoin, tetracyclines, and tazarotene are absolutely contraindicated in pregnancy.
Safe OptionsCategory
Azelaic acid 15–20%Category B
Topical clindamycinCategory B
Topical erythromycinCategory B
BPO (limited use)Category C
Oral azithromycinCategory B
Oral cephalexinCategory B
Intralesional triamcinoloneIn consultation with OB
β€” Dermatology 5e, p. 729

Part VII: Step-up Algorithm & Key Principles

COMEDONAL          β†’  Topical retinoid Β± salicylic acid
       ↓
MILD INFLAMMATORY  β†’  Add BPO + topical antibiotic (short-term)
       ↓
MODERATE           β†’  Add oral tetracycline (≀3 months) + topical retinoid + BPO
                       In females: Consider spironolactone / COCP
       ↓
SEVERE / NODULAR   β†’  Oral isotretinoin (120–150 mg/kg cumulative)
                       Intralesional triamcinolone for nodules
       ↓
ACNE FULMINANS     β†’  Oral corticosteroids FIRST β†’ then isotretinoin (low dose β†’ titrate)
       ↓
MAINTENANCE        β†’  Topical retinoid Β± BPO (long-term)

General Management Principles

  • Treat the entire acne-prone area, not spot treat
  • Allow 6–8 weeks before judging efficacy; full effect at 3–4 months
  • Avoid antibiotic monotherapy β€” always combine with BPO
  • Limit antibiotics to 3–4 months maximum
  • Topical retinoids are the backbone of maintenance therapy
  • Address post-inflammatory hyperpigmentation (PIH) β€” azelaic acid and retinoids help
  • Advise non-comedogenic moisturizers, sunscreens, and cosmetics
  • Do not pick or manipulate lesions
  • Educate about dietary factors (high glycemic index diet may worsen acne)
  • Screen all patients on isotretinoin for depression

Summary Reference Table

Acne SeverityFirst-LineSecond-LineSevere/Refractory
Mild comedonalTopical retinoidBPO, SA, azelaic acidβ€”
Mild papulopustularBPO + topical antibiotic + retinoidDapsone, clascoteroneβ€”
ModerateTopical retinoid + BPO Β± oral tetracyclineSpironolactone/COCP (females)Isotretinoin
Severe nodularOral isotretinoinOral antibiotic + retinoid + BPOIntralesional steroids
Acne conglobataOral isotretinoinOral antibiotic + topical comboBiologics (experimental)
Acne fulminansOral corticosteroids β†’ isotretinoinNSAIDs, BPOβ€”
NeonatalObservation; ketoconazole topicalβ€”β€”
InfantileTopical retinoid + BPOOral erythromycinIsotretinoin (specialist)
Hormonal (female)Spironolactone Β± COCPIsotretinoinβ€”
Drug-inducedDiscontinue offender; topical BPOTopical retinoidOral tetracycline
PregnantTopical clindamycin / azelaic acidOral azithromycin / cephalexinIntralesional triamcinolone

Sources: Dermatology 2-Volume Set 5e (Elsevier), pp. 728–729 | Andrews' Diseases of the Skin 13e, pp. 280–282 | The Harriet Lane Handbook 23e, pp. 282–284 | Katzung's Basic & Clinical Pharmacology 16e

add this with dose of drugs like prescription

Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
I now have all the dosing data needed. Here is the complete, updated treatment guide with full drug doses and prescriptions integrated throughout:

πŸ’Š Comprehensive Acne Treatment Guide β€” With Full Drug Doses & Prescriptions

Sources: Dermatology 2-Volume Set 5e | Andrews' Diseases of the Skin 13e | Harriet Lane Handbook 23e | Katzung's Basic & Clinical Pharmacology 16e

Part I: Understanding Acne β€” Types & Classification

Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit driven by four pathogenic mechanisms:
  1. Follicular hyperkeratinization β†’ comedone formation
  2. Sebaceous gland hyperactivity (androgen-driven excess sebum)
  3. Cutibacterium acnes colonization β†’ inflammatory cascade
  4. Release of proinflammatory cytokines β†’ papules, pustules, nodules, cysts

Lesion Types

LesionDescription
Open comedone (blackhead)Dilated follicle open to surface; oxidized lipids = dark color
Closed comedone (whitehead)Plugged follicle beneath skin
PapuleSmall, raised, red inflammatory lesion < 5 mm
PustulePapule with visible purulent center
NoduleDeep, solid, painful lesion β‰₯ 5 mm
Cyst/pseudocystDeep fluctuant lesion filled with pus/keratin

Clinical Subtypes

TypeKey Features
Comedonal acnePredominantly open/closed comedones, minimal inflammation
Mild papulopustularScattered papules/pustules, few comedones
Moderate papulopustularMultiple papules/pustules, few nodules
Nodular/cystic acneNumerous deep nodules/cysts; high scar risk
Acne conglobataInterconnected nodules, abscesses, sinus tracts; trunk; predominantly males
Acne fulminansSudden explosive nodular acne + systemic features (fever, arthralgia, leukocytosis)
Neonatal acneBirth–6 weeks; Malassezia-driven; self-limiting
Infantile acne2 months–2 years; true comedonal/inflammatory
Acne mechanicaFriction/pressure-induced (helmets, straps)
Drug-induced acneCorticosteroids, androgens, lithium, halogens, phenytoin
Hormonal acne (female)Jawline/chin; perimenstrual flares; PCOS association

Part II: Severity-Based Treatment Algorithm With Doses

🟑 MILD ACNE

Comedonal

Rx First-line:
Tretinoin 0.025% cream β€” apply a pea-sized amount to entire face at night; start every other night Γ— 2 weeks β†’ titrate to nightly as tolerated
Rx Alternative:
Adapalene 0.1% gel β€” apply nightly; may apply morning or evening (light-stable); available OTC
Rx Other alternatives:
Salicylic acid 0.5–2% wash or gel β€” apply once or twice daily (OTC) Azelaic acid 15% gel β€” apply twice daily to affected area

Papulopustular Mild

Rx First-line combo:
Benzoyl peroxide (BPO) 2.5–5% gel/wash β€” apply once daily (morning), leave on β‰₯2 min if wash + Clindamycin 1% gel or lotion β€” apply twice daily (morning + night) to affected area + Tretinoin 0.025% cream or Adapalene 0.1% gel β€” apply nightly
Rx Fixed-combination products (improves adherence):
  • Clindamycin 1.2% / BPO 2.5% gel (Duac/Benzaclin) β€” once daily
  • Adapalene 0.1% / BPO 2.5% gel (Epiduo) β€” once daily
  • Tretinoin 0.1% / Clindamycin 1.2% gel (Ziana) β€” once nightly

🟠 MODERATE ACNE

Rx First-line:
Adapalene 0.3% gel or Tretinoin 0.05% cream β€” nightly to entire face + BPO 5% gel β€” once daily (morning) + Doxycycline 100 mg β€” orally twice daily with food and large glass of water Γ— max 3 months
(Or: Doxycycline modified-release 40 mg once daily β€” equally efficacious, fewer photosensitivity/GI side effects)
Rx In women (hormonal option):
Spironolactone 50–100 mg/day β€” orally once daily; titrate to 100–200 mg/day as tolerated + Combined OCP (e.g., Drospirenone 3 mg / Ethinyl estradiol 0.02 mg [Yaz]) β€” one tablet daily Γ— 21 days, 7 days off
Rx Alternative antibiotic for moderate:
Minocycline 50–100 mg β€” orally twice daily Γ— max 3 months (use if doxycycline not tolerated) Or Sarecycline 1.5 mg/kg/day (weight-based) β€” once daily orally

πŸ”΄ SEVERE ACNE (Nodular/Cystic)

Rx Drug of choice:
Isotretinoin 0.5–1 mg/kg/day β€” orally in 2 divided doses with fatty meal Target cumulative dose: 120–150 mg/kg (reduces relapse risk) Duration: typically 4–6 months (16–20 weeks)
Rx Bridge therapy (while starting isotretinoin):
Oral antibiotic (Doxycycline 100 mg twice daily) + Tretinoin 0.05–0.1% cream + BPO 5% gel
Rx Procedural:
Intralesional Triamcinolone acetonide 2.5–5 mg/mL β€” injected directly into nodule/cyst (Dilute triamcinolone 40 mg/mL to desired concentration with normal saline; inject 0.05–0.1 mL per lesion)

Part III: Drug-by-Drug Prescribing Reference


🧴 A. TOPICAL RETINOIDS β€” Full Formulary

All retinoids: Apply pea-sized amount to entire acne-prone region. Start every-other-night Γ— 2 weeks β†’ daily. Use SPF sunscreen daily. Avoid eyes and nasolabial folds.
DrugVehicleStrengthPregnancy
TretinoinCream0.025%, 0.05%, 0.1%Category C
Gel0.01%, 0.025%
Microsphere gel0.04%, 0.1% (less irritating)
Polymerized cream/gel0.025%
AdapaleneGel0.1% (OTC), 0.3% (Rx)Category C
Cream0.1%
Lotion0.1%
TazaroteneGel0.05%, 0.1%Category X
Cream0.05%, 0.1%
Prescribing example:
Rx: Tretinoin 0.025% cream
Disp: 20 g tube
Sig: Apply a pea-sized amount to entire face at bedtime.
     Start every other night Γ— 2 weeks, then nightly.
     Avoid eyes and corners of nose.
     Use SPF 30+ sunscreen daily.
Refills: 5

🫧 B. BENZOYL PEROXIDE β€” Full Formulary

Available concentrations: 2.5%, 5%, 10% β€” gel, cream, foam, wash, lotion
No bacterial resistance develops. Always co-prescribe with antibiotics.
Standard dosing:
  • Wash (2.5–5%): Apply to affected area, lather, leave 2 minutes, rinse. Once daily (morning).
  • Leave-on gel/cream (2.5–5%): Apply thin layer once or twice daily.
  • Start at 2.5% to minimize irritation; increase to 5–10% as tolerated.
Prescribing example:
Rx: Benzoyl Peroxide 5% gel (or wash)
Disp: 60 g tube
Sig: Apply once daily (morning) to affected areas.
     If wash: leave in contact β‰₯2 minutes before rinsing.
     Warning: Bleaches clothing, towels, bedding.
Refills: 3

🦠 C. TOPICAL ANTIBIOTICS β€” Full Formulary

Never monotherapy β€” always combine with BPO to prevent resistance.
DrugFormulationDose
Clindamycin 1%Gel, lotion, solution, foam, pledgetsApply twice daily (morning + evening)
Erythromycin 2%Gel, solutionApply twice daily; high resistance rates
Dapsone 5% gelGelApply twice daily; avoid applying BPO immediately after (skin discoloration)
Dapsone 7.5% gelGelApply once daily
Topical minocycline 4% foamFoamApply once daily (newer agent)
Prescribing example:
Rx: Clindamycin phosphate 1% gel
Disp: 30 g tube
Sig: Apply a thin layer to affected areas twice daily (AM + PM).
     Use with benzoyl peroxide wash in the morning.
Refills: 2

πŸ’Š D. ORAL ANTIBIOTICS β€” Full Prescribing Details

Rule: Always combine with BPO Β± topical retinoid. Limit to 3 months maximum.

1. Doxycycline (First-line, preferred)

IndicationDose
Moderate acne100 mg orally twice daily with food
Sub-antimicrobial (anti-inflammatory, equal efficacy)40 mg modified-release (Oracea) once daily OR 20 mg twice daily
Severe acne100 mg twice daily initially; step down once controlled
Age restrictionβ‰₯ 8 years only
Side effects: Photosensitivity (use sunscreen), GI upset, esophagitis (take with full glass of water, remain upright β‰₯1 hour), vaginal candidiasis.
Rx: Doxycycline hyclate 100 mg tablets
Disp: 60 tablets (#60)
Sig: Take 1 tablet by mouth twice daily with food and
     a full glass of water. Remain upright β‰₯1 hour.
     Avoid prolonged sun exposure; use SPF 30+.
     Duration: 3 months (do not use longer without review).
Refills: 0

2. Minocycline

FormDose
Immediate release50–100 mg orally twice daily
Extended release (weight-based, preferred)~1 mg/kg/day once daily (45 mg for <60 kg; 90 mg for 60–90 kg; 135 mg for >90 kg)
Side effects: Vestibular toxicity (dizziness/vertigo β€” common at onset), cutaneous/mucosal pigmentation, drug-induced lupus-like syndrome, drug hypersensitivity syndrome (within first 1–2 months), SJS (rare).
⚠️ More serious adverse events than doxycycline β€” many guidelines now prefer doxycycline as first-line.
Rx: Minocycline extended-release 90 mg tablets
Disp: 90 tablets
Sig: Take 1 tablet orally once daily with or without food.
     Duration: 3 months maximum.
     Warn: dizziness on first few doses; pigmentation changes.
Refills: 0

3. Sarecycline (Narrow-spectrum tetracycline, β‰₯9 years)

WeightDose
33–54 kg60 mg once daily
55–84 kg100 mg once daily
85–136 kg150 mg once daily
Advantages: Narrow antimicrobial spectrum (less disruption of gut microbiome), fewer GI/photosensitivity side effects.
Rx: Sarecycline 100 mg tablet
Disp: 90 tablets
Sig: Take 1 tablet orally once daily with or without food.
     Duration: 3 months.
Refills: 0

4. Erythromycin (Pregnancy/age <8 years)

IndicationDose
Moderate acne (β‰₯12 years)500 mg orally twice daily
Children <8 years30–50 mg/kg/day in divided doses
Infantile acne125–250 mg twice daily
⚠️ High resistance rates worldwide β€” reserve for pregnancy or pediatric cases.

5. Azithromycin (Pregnancy/tetracycline intolerance)

Dose scheduleRegimen
Pulse dosing500 mg orally once daily Γ— 3 days per week for 4–12 weeks
Alternate250 mg once daily daily use

6. Trimethoprim-Sulfamethoxazole (TMP-SMX)

  • Dose: TMP 160 mg / SMX 800 mg (double-strength) β€” 1 tablet twice daily
  • Use only for antibiotic-resistant cases or failed tetracyclines/macrolides
  • Risk of severe adverse reactions (SJS, agranulocytosis) limits routine use

β˜€οΈ E. ORAL ISOTRETINOIN β€” Complete Prescribing Guide

Indicated for: Severe nodular/cystic acne, acne with scarring, relapsing moderate acne, acne conglobata, acne fulminans (after steroids), severe acne resistant to antibiotics.

Dosing Protocol

PhaseDoseNotes
Starting dose0.5 mg/kg/day in 2 divided dosesTake with fatty meal (↑ absorption ~50%)
Titration (if tolerated)1 mg/kg/day in 2 divided dosesAfter 4–8 weeks if tolerating
Target cumulative dose120–150 mg/kg totalAssociated with lowest relapse rate
Duration16–20 weeks (4–5 months) typicalExtend if cumulative dose not reached
Low-dose protocol (adults)0.25–0.5 mg/kg/dayFewer side effects; longer course needed
Acne fulminansStart 10–20 mg/day Γ— 4 weeks (after 2–4 weeks of prednisolone)Then titrate gradually
Example for 70 kg patient:
Starting: 35 mg/day (0.5 mg/kg) Γ— 4 weeks
Titrate:  70 mg/day (1 mg/kg) Γ— remaining course
Target cumulative: 70 Γ— 120 = 8,400 mg total

Pre-treatment Workup (Before Starting)

TestTiming
Pregnancy test (females)Baseline, monthly
Fasting lipid panelBaseline, at 4 weeks, 8 weeks
LFTs (AST, ALT)Baseline, 4 weeks, 8 weeks
CBCBaseline
Depression screeningBaseline and each visit

Side Effect Management

Side EffectManagement
Cheilitis (universal)Petroleum jelly/lip balm multiple times daily
Dry skin/eczemaNon-comedogenic moisturizer; gentle cleanser
Dry eyesArtificial tears; avoid contact lenses if severe
NosebleedsNasal saline; petroleum jelly in nostrils
HypertriglyceridemiaDietary fat restriction; reduce dose; add fenofibrate if TG >500 mg/dL
LFT elevationReduce dose; stop if >3Γ— ULN
Musculoskeletal painNSAIDs; reduce dose
Teratogenicity2 forms contraception + monthly pregnancy test (iPLEDGE)
Pseudotumor cerebriNever combine with tetracyclines
Contraindications: Pregnancy (absolute), breastfeeding, severe hyperlipidemia, hepatic failure.
Rx: Isotretinoin (Accutane/generic) 20 mg soft gelatin capsules
Disp: 60 capsules
Sig: Take 1 capsule (20 mg) twice daily with meals
     (start 0.5 mg/kg/day; titrate to 1 mg/kg/day).
     Target total dose: 120–150 mg/kg.
     Enrolled in iPLEDGE program.
     No pregnancy β€” two forms contraception required.
     Labs at weeks 4 and 8 (lipids, LFTs, CBC).
Refills: Per iPLEDGE (monthly Rx only)

🩺 F. HORMONAL THERAPY β€” Full Prescribing

1. Spironolactone (Women only)

PhaseDose
Starting50 mg orally once daily
Maintenance100 mg/day (most effective dose)
Maximum200 mg/day (split into twice daily)
Duration3–6 months for initial response; can use long-term
Monitoring: Serum potassium (baseline, 1 month, then periodically); BP; menstrual cycle regularity.
Side effects: Menstrual irregularity (co-prescribe OCP), breast tenderness, polyuria, dizziness, hyperkalemia.
Rx: Spironolactone 100 mg tablets
Disp: 90 tablets
Sig: Take 1 tablet orally once daily.
     Monitor potassium at 1 month.
     Use reliable contraception (teratogenic).
     Avoid in pregnancy and with ACE-I/ARB.
Refills: 2

2. Combined Oral Contraceptives (FDA-approved for acne)

BrandCompositionDose
Yaz (most anti-androgenic)Drospirenone 3 mg + EE 0.02 mg1 tablet daily Γ— 21 days, 7-day break
Ortho Tri-CyclenNorgestimate + EE (triphasic)1 tablet daily Γ— 28 days
Estrostep FeNorethindrone + EE (triphasic)1 tablet daily Γ— 28 days
Onset of acne benefit: 3–6 menstrual cycles. Meta-analysis shows equivalence to oral antibiotics at 6 months for inflammatory acne.
Contraindications: Smokers >35 years, history of VTE/stroke, migraine with aura, hormone-sensitive cancer.
Rx: Drospirenone 3 mg / Ethinyl Estradiol 0.020 mg (Yaz)
Disp: 1 blister pack (28 tablets)
Sig: Take 1 tablet daily at same time; follow pack sequence
     (24 active + 4 inert tablets).
Refills: 11

πŸ”¬ G. OTHER TOPICAL AGENTS WITH DOSES

DrugConcentrationDoseNotes
Azelaic acid15% gel (Finacea) / 20% cream (Azelex)Apply twice daily to affected areaLightens PIH; safe in pregnancy (Cat B)
Salicylic acid0.5–2% wash, gel, padsApply once or twice dailyOTC; comedolytic
Clascoterone1% cream (Winlevi)Apply twice daily to affected areaTopical androgen receptor blocker; β‰₯12 years
Niacinamide2% gelApply twice dailyNon-inferior to clindamycin 1% for moderate acne
Sodium sulfacetamide 10% / Sulfur 5%Cream, lotion, washApply once or twice dailyMild; also useful in rosacea
Prescribing example (azelaic acid):
Rx: Azelaic acid 15% gel (Finacea)
Disp: 30 g tube
Sig: Apply a thin layer to affected areas twice daily
     (morning and evening) after washing face.
     Safe in pregnancy. May sting initially.
Refills: 3

Part IV: Special Acne Variants β€” Specific Doses

πŸ”΄ Acne Conglobata β€” Treatment

  1. Oral isotretinoin 1 mg/kg/day in 2 divided doses; cumulative 150 mg/kg
  2. Bridge: Doxycycline 100 mg twice daily + topical retinoid + BPO (while isotretinoin takes effect)
  3. Intralesional triamcinolone 5 mg/mL into individual nodules
  4. Surgical: I&D of fluctuant abscesses
  5. Refractory: Oral dapsone 50–100 mg/day; adalimumab (biologic β€” off-label)

πŸ”₯ Acne Fulminans β€” Stepwise Protocol

⚠️ Do NOT start high-dose isotretinoin acutely β€” risk of paradoxical worsening.
StepDrugDose & Duration
Step 1Prednisolone0.5–1 mg/kg/day orally Γ— 2–4 weeks; then taper over 4–8 weeks
Step 2Isotretinoin (low start)10–20 mg/day (start Week 2–4 of steroids)
Step 3Titrate isotretinoinIncrease to 0.5 mg/kg/day β†’ 1 mg/kg/day while tapering steroids
AdjunctNaproxen or Ibuprofen400–600 mg 3Γ—/day for arthralgia and fever
TopicalBPO 5% + topical retinoidAs adjuncts throughout

πŸ‘Ά Neonatal & Infantile Acne β€” Dosing

Neonatal (0–6 weeks):
Rx: Ketoconazole 2% cream
Sig: Apply to affected area twice daily Γ— 4–6 weeks
     (if Malassezia-driven neonatal cephalic pustulosis confirmed)
Infantile (2 months–2 years):
  • Mild: Adapalene 0.1% gel β€” apply every other night; BPO 2.5% wash
  • Moderate: Erythromycin ethylsuccinate 30–50 mg/kg/day in 3–4 divided doses orally Γ— 6–8 weeks
  • Rule out androgen excess (measure testosterone, DHEAS, 17-OH progesterone)

πŸ‘© Hormonal/Adult Female Acne β€” Prescription Summary

First-choice:
Rx: Spironolactone 100 mg daily + Yaz 1 tablet daily
    + Adapalene 0.3% gel nightly + BPO 5% wash AM
Second-choice if OCP contraindicated:
Rx: Spironolactone 100–200 mg daily alone
    (with reliable non-hormonal contraception)

πŸ’Š Drug-Induced Acne

  • Discontinue offending drug when possible
  • Corticosteroid-induced (monomorphic pustular): BPO 5% gel once daily; Doxycycline 100 mg twice daily if widespread
  • EGFR inhibitor acne: Topical clindamycin 1% + topical steroid (mild); doxycycline 100 mg twice daily (moderate–severe)

🀰 Pregnancy-Safe Acne Treatment β€” Prescriptions

DrugPregnancy CategoryDose
Azelaic acid 15–20%BTwice daily topically
Topical clindamycin 1%BTwice daily topically
Topical erythromycin 2%BTwice daily topically
BPO 2.5–5%C (limited use)Once daily wash
Azithromycin 500 mgB500 mg 3Γ—/week pulse Γ— 6–8 weeks
Cephalexin 500 mgB250–500 mg twice daily Γ— 3–4 months
Intralesional triamcinolone 2.5–5 mg/mL(consult OB)Per nodule; office procedure
❌ Absolutely contraindicated in pregnancy: Isotretinoin, all tetracyclines, tazarotene, spironolactone.

Part V: Procedural Treatments With Doses

ProcedureDrug/DeviceDose/Technique
Intralesional steroidTriamcinolone acetonide 2.5–5 mg/mL0.05–0.1 mL per lesion; dilute 40 mg/mL stock with NS
Chemical peelSalicylic acid 20–30%; Glycolic acid 30–70%Applied by dermatologist; 2–4 sessions q3–4 weeks
PDTAminolevulinic acid 20% + red/blue lightApplied 30–60 min before light activation; 2–4 sessions
Blue light415 nm8–10 min sessions, 2Γ— weekly Γ— 4–8 weeks
Fractional COβ‚‚ laser10,600 nmFor acne scarring; 3–5 sessions q4–8 weeks
Subcision18-gauge needle or Nokor needleBreaks fibrous scar bands; for rolling scars

Part VI: Maintenance Therapy

After achieving control, switch to maintenance to prevent relapse:
Maintenance Rx (standard):
Adapalene 0.1% gel β€” apply nightly to entire face
Β± BPO 2.5% wash β€” once daily (especially if was on antibiotics)

Duration: Indefinite (months to years as needed)
Topical retinoids alone are the gold standard maintenance β€” they prevent new comedone formation and address subclinical microcomedones.

Part VII: Summary Prescribing Reference by Severity

SeverityTypical Prescription Combination
Mild comedonalTretinoin 0.025% cream nightly
Mild papulopustularBPO 5% wash (AM) + Clindamycin 1% gel (PM) + Adapalene 0.1% gel (night)
ModerateDoxycycline 100 mg BID Γ— 3 months + Adapalene 0.3% nightly + BPO 5% wash daily
Moderate (female)Spironolactone 100 mg daily + Yaz + Adapalene 0.3% nightly
Severe nodularIsotretinoin 0.5 β†’ 1 mg/kg/day; cumulative 120–150 mg/kg
Acne conglobataIsotretinoin 1 mg/kg/day + intralesional triamcinolone
Acne fulminansPrednisolone 0.5–1 mg/kg/day β†’ Isotretinoin 10 mg/day β†’ titrate
NeonatalKetoconazole 2% cream BID (if needed)
Infantile moderateErythromycin 30–50 mg/kg/day in divided doses
PregnantTopical clindamycin 1% + Azelaic acid 15% BID
MaintenanceAdapalene 0.1% gel nightly Β± BPO 2.5% wash

Sources: Dermatology 2-Volume Set 5e, pp. 728–729 | Andrews' Diseases of the Skin 13e, pp. 280–283 | Harriet Lane Handbook 23e, pp. 282–285 | Katzung's Basic & Clinical Pharmacology 16e
⚠️ Clinical Disclaimer: All prescriptions should be individualized based on patient age, weight, comorbidities, contraindications, and local antibiotic resistance patterns. Isotretinoin requires enrollment in the iPLEDGE REMS program in the USA.
This is a shared conversation. Sign in to Orris to start your own chat.